Detalles de la búsqueda
1.
A Phase I, Randomized, Double-Blind, Laser-Evoked Potential Study to Evaluate the Analgesic/Antihyperalgesic Effect of ASP9226, a State-Dependent N-Type Voltage-Gated Calcium Channel Inhibitor, in Healthy Male Subjects.
Pain Med
; 19(11): 2246-2255, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29378016
2.
The MOBILE Study-A Phase IIa Enriched Enrollment Randomized Withdrawal Trial to Assess the Analgesic Efficacy and Safety of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Patients with Peripheral Neuropathic Pain.
Pain Med
; 18(12): 2388-2400, 2017 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28383710
3.
Single-Dose Interaction Study of the Arginine Vasopressin Type 1B Receptor Antagonist ABT-436 and Alcohol in Moderate Alcohol Drinkers.
Alcohol Clin Exp Res
; 40(4): 838-45, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26969417
4.
Suicidality and divalproex sodium: analysis of controlled studies in multiple indications.
Ann Gen Psychiatry
; 10(1): 1, 2011 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-21244672
5.
Efficacy and Safety of ASP0819 in Patients with Fibromyalgia: Results of a Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial.
J Pain Res
; 13: 3355-3369, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33328761
6.
Clobazam in the treatment of Lennox-Gastaut syndrome.
Epilepsia
; 50(5): 1158-66, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19170737
7.
Hypothalamic-pituitary-adrenal axis and depression symptom effects of an arginine vasopressin type 1B receptor antagonist in a one-week randomized Phase 1b trial.
Brain Behav
; 7(3): e00628, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28293470
8.
A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence.
Neuropsychopharmacology
; 42(5): 1012-1023, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27658483
9.
Clinical safety and hypothalamic-pituitary-adrenal axis effects of the arginine vasopressin type 1B receptor antagonist ABT-436.
Psychopharmacology (Berl)
; 233(1): 71-81, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26407603
10.
Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders.
Neuropsychopharmacology
; 28(6): 1186-97, 2003 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12700713
11.
Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.
Neuropsychopharmacology
; 28(1): 182-92, 2003 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-12496955
12.
The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.
J Clin Psychiatry
; 64(7): 841-6, 2003 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12934987
13.
An open-label trial of divalproex in children and adolescents with bipolar disorder.
J Am Acad Child Adolesc Psychiatry
; 41(10): 1224-30, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12364844
14.
A novel approach to assess inter-rater reliability in the use of the Overt Aggression Scale-Modified.
Psychiatry Res
; 112(2): 153-9, 2002 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-12429361
15.
Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone.
Psychiatr Serv
; 55(3): 290-4, 2004 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15001730
Resultados
1 -
15
de 15
1
Próxima >
>>